MABION

Mabion is a Contract Development and Manufacturing Organisation (CDMO) that provides comprehensive solutions in the biologics sector. Specialising in the development, production, and manufacturing of monoclonal antibodies and other biologic products, the company serves the global healthcare market with a strong commitment to quality and innovation.

Founded in 2007 and headquartered in Poland, Mabion supports the pharmaceutical industry with services that span from drug substance manufacturing to final product fill and finish. The company is equipped with state-of-the-art facilities, providing end-to-end support to biopharma companies.

Key Products and Services

• Drug substance manufacturing
• Fill and finish services
• End-to-end biologics development (Gene to Vial)
• Process development
• Analytical services
• Cell line development and banking

Mabion continues to enhance its capabilities and expand its service offerings, maintaining its position as a leading partner for biologics companies.